Raymond Prudo-Chlebosz - Director at Akari Therapeutics Plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AKTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Raymond Prudo-Chlebosz since 4/23/2024

Holdings reported by Raymond Prudo-Chlebosz for Akari Therapeutics Plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares, par value $0.0001 per share 4.08B $4.89M $0.00 Dec 2, 2024 Direct
American Depositary Shares representing Ordinary Shares 2.48M $2.78M $1.12 Mar 20, 2025 Direct
Ordinary Shares, par value $0.0001 per share 801M $961K $0.00 Dec 2, 2024 RPC Pharma Limited
Warrants (Right to Buy) 419M $503K $0.00 Dec 2, 2024 Direct Ordinary Shares, par value $0.0001 per share
Series A Warrants (Right to Buy) 446K $500K $1.12 Mar 6, 2025 Direct American Depositary Shares representing Ordinary Shares
Series B Warrants (Right to Buy) 446K $500K $1.12 Mar 6, 2025 Direct American Depositary Shares representing Ordinary Shares
American Depositary Shares representing Ordinary Shares 400K $448K $1.12 Mar 20, 2025 RPC Pharma Limited
Ordinary Shares, par value $0.0001 per share 38.7M $46.5K $0.00 Dec 2, 2024 Praxis Trustees Limited
American Depositary Shares representing Ordinary Shares 19.4K $21.7K $1.12 Mar 20, 2025 Praxis Trustees Limited
Ordinary Shares, par value $0.0001 per share 3.66B May 31, 2024 Direct
Ordinary Shares, par value $0.0001 per share 801M May 31, 2024 RPC Pharma Limited
Ordinary Shares, par value $0.0001 per share 38.7M May 31, 2024 Praxis Trustees Limited
Stock Option (Right to Buy) 225K Mar 20, 2025 Direct American Depositary Shares representing Ordinary Shares

Transactions reported by Raymond Prudo-Chlebosz for Akari Therapeutics Plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.